Handelsbanken Fonder Ab Biomarin Pharmaceutical Inc Transaction History

Handelsbanken Fonder Ab

$23 Billion
Q2 2024

A detailed history of Handelsbanken Fonder Ab transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 121,566 shares of BMRN stock, worth $8.58 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

121,566

Previous 96,812 25.57%

Holding current value

$8.58 Million

Previous $8.46 Million 18.37%

% of portfolio

0.04%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$74.43 - $92.22 $1.84 Million - $2.28 Million	24,754 Added 25.57%	121,566 $10 Million
Q1 2024 May 13, 2024	BUY	$83.81 - $99.0 $566,723 - $669,438	6,762 Added 7.51%	96,812 $8.46 Million
Q4 2023 Feb 01, 2024	SELL	$76.22 - $98.51 $129,955 - $167,959	-1,705 Reduced 1.86%	90,050 $8.68 Million
Q3 2023 Oct 19, 2023	BUY	$85.07 - $94.48 $135,516 - $150,506	1,593 Added 1.77%	91,755 $8.12 Million
Q2 2023 Aug 02, 2023	BUY	$86.68 - $100.3 $1.08 Million - $1.25 Million	12,451 Added 16.02%	90,162 $7.82 Million
Q1 2023 Apr 28, 2023	BUY	$87.74 - $117.27 $211,277 - $282,386	2,408 Added 3.2%	77,711 $7.56 Million
Q4 2022 Feb 07, 2023	BUY	$80.93 - $108.63 $408,210 - $547,929	5,044 Added 7.18%	75,303 $7.79 Million
Q2 2022 Aug 03, 2022	SELL	$71.48 - $86.85 $16.6 Million - $20.2 Million	-232,242 Reduced 76.77%	70,259 $5.82 Million
Q1 2022 May 11, 2022	SELL	$74.28 - $92.69 $285,978 - $356,856	-3,850 Reduced 1.26%	302,501 $23.3 Million
Q4 2021 Feb 08, 2022	BUY	$71.72 - $91.47 $6.12 Million - $7.81 Million	85,338 Added 38.61%	306,351 $27.1 Million
Q3 2021 Nov 10, 2021	BUY	$74.77 - $85.47 $332,203 - $379,743	4,443 Added 2.05%	221,013 $17.1 Million
Q2 2021 Aug 03, 2021	BUY	$75.51 - $84.79 $13.1 Million - $14.7 Million	173,799 Added 406.35%	216,570 $18.1 Million
Q1 2021 Apr 29, 2021	SELL	$74.73 - $90.69 $31,386 - $38,089	-420 Reduced 0.97%	42,771 $3.23 Million
Q4 2020 Feb 11, 2021	SELL	$72.61 - $90.2 $7,115 - $8,839	-98 Reduced 0.23%	43,191 $3.79 Million
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $114,992 - $209,648	1,600 Added 3.84%	43,289 $3.29 Million
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $3.32 Million - $5.18 Million	41,689 New	41,689 $5.14 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Biomarin Pharmaceutical Inc Transaction History